Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2007-04, Vol.21 (4), p.838-842
Hauptverfasser:	Bonvini, P, Zorzi, E, Basso, G, Rosolen, A
Format:	Artikel
Sprache:	eng
Schlagworte:	Anaplastic large-cell lymphoma Antineoplastic Agents - pharmacology Apoptosis Apoptosis - drug effects Boronic Acids - pharmacology Bortezomib Cancer Research Cell Cycle - drug effects Cell Division - genetics Cell Line, Tumor Critical Care Medicine Enzyme Inhibitors - pharmacology G2 Phase - drug effects Hematology Humans Intensive Internal Medicine letter-to-the-editor Lymphoma Lymphoma, Large B-Cell, Diffuse - pathology Medicine Medicine & Public Health Oncology Proteasome 26S Proteasome Endopeptidase Complex Proteasome Inhibitors Pyrazines - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!